TRNDi005-A

Registration Summary:

A P E C

iPSC HT438A

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	TRNDi005-A
Cite as:	TRNDi005-A (RRID:CVCL_UL24)
Alternative name(s)	iPSC HT438A
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	27th March 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	NIH/NCATS-TRND Branch (TRND)
External iPSC Databases
Cellosaurus	CVCL_UL24
Wikidata	Q98133593
General iPSC Information
Publications	Li R et al. Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene. Stem cell research. 2019 Apr;36:101408. Puentes-Tellez MA et al. A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia. Heliyon. 2020 Mar;6(3):e03635. Santos HS et al. Genome editing in mucopolysaccharidoses and mucolipidoses. Progress in molecular biology and translational science. 2021;182:327-351. Lehmann RJ et al. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells. Molecular genetics and metabolism reports. 2021 Dec;29:100811. Leal Andrés Felipe et al. Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks. International Journal of Molecular Sciences. 2023-11-09. Jiang X et al. Diminished GALNS activity in induced pluripotent stem cells of mucopolysaccharidosis IVA caused by compound p.S162Y and p.C165F mutation. QJM: An International Journal of Medicine. 2025-01-01.

iPSC Derivation

General